Zynex CEO Cleans House, Clears Out Board

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Zynex CEO Thomas Sandgaard downsizes the company’s board of directors as part of a larger strategy to restructure the company. Zynex (OTC:ZYXI) CEO Thomas Sandgaard has cleared the path to reshape the company after cutting its board in half. Sandgaard asked for the resignations of board members Mats Wahlstrom, Mary Beth Vitale, Kevin Smith and Taylor Simonton, to add board members who share Sandgaard’s vision for the rehab devices maker.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC